The following is a summary of “St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time ...
Clinical Trials Arena on MSN16h
Biofrontera enrols all subjects in trial of topical gel for actinic keratosesUS-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...
The firms said that they will integrate Primaa's skin cancer testing algorithms with Gestalt's PathFlow digital pathology software platform.
Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a ...
Gestalt's PathFlow is known for its versatility, supporting primary diagnoses*, education, resident training, and research workflows. By integrating Primaa's advanced AI algorithms, the platform now ...
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback